Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Uncategorized

Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets

Published

on

clarivate-launches-latam-market-tracking-solution-in-partnership-with-global-healthcare-intelligence-enabling-real-time-tracking-of-medical-device-markets

 
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its LatAm market tracking solution, in collaboration with Global Healthcare Intelligence, a leading provider of market intelligence on healthcare infrastructure in frontier markets.
The new solution is the next phase of an expanding partnership between Clarivate and Global Healthcare Intelligence, enabling in-depth and actionable analysis of the medical device market in Latin America (LatAm). Leveraging comprehensive datasets and the proprietary Clarivate device catalog for the LatAm region, including Brazil, Colombia, Argentina, Chile, Peru, and Ecuador, clients can analyze over 100 medical devices and 500 product categories.
The LatAm medical equipment and device markets have seen substantial growth, currently valued at $10 billion annually, with key players Brazil, Mexico, Colombia, Argentina, and Chile accounting for 89% of the regional market, and underscoring LatAm’s pivotal role in the global healthcare industry.1 This surge in market value reflects the increasing demand for cutting-edge medical technologies and the region’s continuous commitment to enhance healthcare infrastructure and accessibility.
Andrew Lee, Vice President Medtech, Life Sciences & Healthcare, Clarivate, said: “As the LatAm medical device market has observed significant expansion in recent years, there is a growing need for an unbiased source of data that will empower medical equipment and device manufacturers to make informed decisions. In partnership with Global Healthcare Intelligence, LatAm market tracking for Clarivate leverages curated and validated ready-to-access information, quarter after quarter, equipping customers with consistent insight and foresight needed to create innovative treatments, deliver them to patients faster and improve quality of life.”
Guillaume Corpart, Founder and CEO, Global Health Intelligence, said: “Latin America poses unique challenges in regard to accessing reliable market information. We are thrilled to have partnered with Clarivate to deliver this game-changing solution. Medical equipment & Medical device manufacturers are now able to assess market potential and track performance in a consistent and accurate manner across the region’s leading countries.”
The Clarivate LatAm team of experts support medical device companies and distributors in harnessing the comprehensive real-time data provided by the Clarivate LatAm market tracking solution. From detailed SKU-level data and independent, third-party analysis to share price and market trends, clients can leverage the solution to market their brands more effectively in the region. To learn more about LatAm market tracking solution, visit here.
The post Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets appeared first on HIPTHER Alerts.

Continue Reading

Uncategorized

Azentio Software wins three honours at IBSi Digital Banking Awards 2024

Published

on

azentio-software-wins-three-honours-at-ibsi-digital-banking-awards-2024

 
Azentio Software (“Azentio”), a Singapore-headquartered technology firm owned by funds advised by Apax Partners, announced today that it has won three awards with its respective clients, at the IBSi Digital Banking Awards 2024 ceremony, held as a part of the prestigious Cedar-IBSi Digital Banking & AI Summit, on April 19 in Bengaluru, India. The company was declared Segment Winners I SME/Corporate Banking, Regional Winners I Middle East & Africa, and Segment Winners I Compliance Management.
Organised by IBS intelligence (IBSi), one of the world’s leading financial technology research, advisory, and news analysis firm firms, the annual award program honours technology players, Banking as a Service (BaaS) providers, digital banks, neo banks, and challenger banks for their excellence in driving impact through technology implementations and innovations using emerging technologies.
The Azentio Accolades

Digital Badge of Segment Winners I SME/Corporate Banking
Digital Badge of Regional Winners I Middle East & Africa
Digital Badge of Segment Winners I Compliance Management

Azentio’s citations as Segment Winners I SME/Corporate Banking and Regional Winners I Middle East & Africa, were for the successful implementation of the Azentio ONEBanking Digital Lending platform at Consolidated Bank Ghana Limited (CBG), one of the largest banks in Ghana. CBG has leveraged Azentio ONEBanking to seamlessly integrate digital processes and online services, thereby, enhancing customer experience with convenient, secure, and efficient banking solutions. This digital shift not only streamlines operations for the bank but also reinforces its commitment to modernizing the banking sector in Ghana.
Azentio was declared Segment Winners I Compliance Management for maximizing the technology benefits for Albilad Investment Company (Albilad Capital), a leading provider of Islamic investment management solutions in the Kingdom of Saudi Arabia (KSA), with its Azentio ONEBanking Financial Crime Management (FCM) platform. Azentio FCM has emerged as a cornerstone in Albilad Capital’s compliance strategy, offering a blend of regulatory adherence, operational agility, and cost-effectiveness. Its robust features and seamless integration have not only fortified the institution’s compliance framework but also positioned it as a trusted player in the regional financial landscape.
Nikhil Gokhale, Director – Research & Digital Properties at IBS Intelligence, stated, “Congratulations to Consolidated Bank Ghana and Azentio for their win at the IBSi Digital Banking Awards 2024. By using Azentio ONEBanking, CBG has revolutionized its operations, improving customer service and operational efficiency. Their strategic approach to digital innovation ensures ongoing growth and competitiveness in the finance sector. At the same time, kudos to Albilad Capital and Azentio for winning the ‘Best in Compliance’ award. Albilad Capital’s adoption of Azentio ONEBanking Financial Crime Management has significantly enhanced compliance, efficiency, and cost-effectiveness,” continued Nikhil. “The solution’s integration with the Saudi Arabian Monetary Authority (SAMA) guidelines ensures strict adherence to anti-money laundering policies, establishing credibility in the business.”
Gaurav Kedia, Chief Financial Officer at Azentio Software, commented, “We are humbled and proud for these multiple honours bestowed upon Azentio by the globally renowned IBSi, for our focus on bringing tremendous value for clients with our innovative technology solutions. Azentio ONEBanking Digital Lending gives maximum support for scalability, compliance and digitalization, with its advanced cloud-native, auto-scalable, low-code/no-code, and API-ready features that completely transform end-to-end lending processes for our clients and their customers. Additionally, Azentio ONEBanking FCM stands out as a highly parameterized, domain-agnostic platform that includes a comprehensive AML solution and AI-driven analytical and investigative tools. These tools provide critical, actionable intelligence to detect and prevent money laundering and fraudulent activities effectively. Clearly Azentio helps its clients lead the way in modernization, transformation and innovation.”
The post Azentio Software wins three honours at IBSi Digital Banking Awards 2024 appeared first on HIPTHER Alerts.

Continue Reading

Uncategorized

BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report

Published

on

bioworld-by-clarivate-explores-the-future-of-car-t-therapy-in-mainland-china-in-special-report

 
BioWorld published by  Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled “China’s CAR T market comes of age.” The report examines the dynamic realm of CAR T-cell therapies in China, including the rapid pipeline growth, deals, clinical trials and challenging issues surrounding patient access to very expensive and effective cancer therapeutics.
CAR T (Chimeric Antigen Receptor T-cell) therapy represents a revolutionary approach to cancer treatment, harnessing the power of the body’s immune system to target and destroy cancer cells. As this groundbreaking treatment gains traction in the pharmaceutical sphere, the BioWorld special report provides valuable insights into its present state and future potential. The report, authored by Tamra Sami, Ruchita Kumar, and Sahil Arora, covers three key topics:

Part One: China’s investigator trials accelerate competitive CAR T developmentThe exponential growth of China’s CAR T market is projected to soar from $72 million in 2022 to an impressive $342 million over the next decade. With over 400 CAR T therapies currently in the pipeline, fueled by strategic collaborations between multinational pharma giants and local biotechs, this segment promises unprecedented opportunities for growth and innovation.
Part Two: CAR T pipelines bloom to treat world’s largest cancer populationAs of Jan. 31, 2024, there were more than 300 CAR T trials registered in China, surpassing the U.S. and becoming the country with the most CAR T therapy clinical trials. Among them, CD19 is the most frequently studied target. The rapid evolution of CAR T-cell therapies in China has escalated over the past decade from the start of the first clinical trials in 2013 to the country becoming an established host for CAR T-cell-related trials by 2017.
Part Three: China grapples with providing access to CAR T therapiesThe process of manufacturing autologous T-cell therapies is technically challenging when compared with other oncology drugs, making the overall cost of developing CAR T therapies significantly higher. A challenging reimbursement environment for drugs in China also means that most patients will have to pay out of pocket to access CAR T therapies. Taken together, complex logistics – production, manufacturing and supply chain – and complicated administration requirements are key bottlenecks that inflate the input costs involved in developing these specialized treatment options.

Lynn Yoffee, Publisher, BioWorld, said: “China’s quest to become the world leader in biopharmaceutical innovation may be gaining momentum even as countries sort through complex licensing and patent rights challenges. One thing is clear: China is now the leader in studying CAR T therapies with the most clinical trials, surpassing the U.S. How patients will be able to pay for these expensive treatments out of pocket given China’s challenging reimbursement system remains in question. The BioWorld special report investigates how CAR T development is coming of age in a country with the world’s second-largest population.”
For more exclusive in-depth coverage of the evolution of China’s CAR T landscape, visit here.
Join the conversation and mention BioWorld on X and LinkedIn as well as Clarivate for Life Sciences & Healthcare on X and LinkedIn.
The post BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report appeared first on HIPTHER Alerts.

Continue Reading

Uncategorized

Chinese new energy industry contributes to global green, low-carbon transition

Published

on

chinese-new-energy-industry-contributes-to-global-green,-low-carbon-transition

 
In recent years, China’s new energy industry has developed rapidly, and international cooperation in this field has accelerated.
The international community pays close attention to the development of China’s new energy industry, believing that China has made significant contributions to global green and low-carbon transformation and has become an important driver for global energy transition and climate change mitigation.
China’s new energy industry has made positive contributions to global emissions reduction. Since the introduction of the “dual carbon” goals in 2020, which means peaking carbon dioxide emissions by 2030 and achieving carbon neutrality by 2060, China has steadfastly fulfilled its commitments, accelerating the transformation of its energy structure and promoting the rapid development of renewable energy.
According to a report by the International Energy Agency, the global annual renewable capacity additions stood at 510 million kilowatts last year, and China contributed over half to this figure, making a tremendous contribution to the growth of global renewable energy generation.
Chinese wind and solar products have been exported to over 200 countries and regions worldwide, helping developing countries access clean, reliable, and affordable energy.
In 2022, China’s renewable energy generation was equivalent to reducing domestic CO2 emissions by approximately 2.26 billion tons, and the exported wind and solar products helped other countries reduce CO2 emissions by approximately 573 million tons. The two figures added up to 2.8 billion tons of emissions, or about 41 percent of the world’s total carbon emissions reduction converted from renewable energy.
China’s new energy technologies have provided significant support for global green and low-carbon transformation. After years of development, China has become a global leader in various new energy technologies and equipment manufacturing. It has established the world’s largest clean power supply system, and Chinese new energy vehicles, lithium batteries, and photovoltaic products have brought new hopes to global climate change mitigation efforts.
From the connection of the world’s first 16-megawatt offshore wind turbine to the power grid to the commercial operation of the world’s first fourth-generation nuclear power plant, and from a new power battery enabling a range of 1,000 kilometers on a single charge to intelligent cabins equipped with artificial intelligence models, China’s new energy industry is contributing wisdom and strength to global energy transformation through its innovation and reliability.
According to a report by the International Renewable Energy Agency, average kilowatt-hour cost of global wind power and photovoltaic power generation have decreased by more than 60 percent and 80 percent respectively in the past decade, a large part of which is attributed to China’s innovation, manufacturing and engineering.
Fatih Birol, executive director of the International Energy Agency, highlighted that China’s provision of services and support to other countries has significantly improved the accessibility of clean energy technologies and reduced the global cost of using green technologies.
China is promoting cooperation in the new energy industry in an orderly manner and building a new model for green and low-carbon energy transformation that benefits all.
The Al Shuaibah Solar Photovoltaic Project, constructed by a Chinese company in Saudi Arabia, is expected to reduce carbon dioxide emissions by 245 million tons over 35 years, equivalent to planting 545 million trees.
A solar photovoltaic park, jointly built by a Chinese company and its European partners, will provide green electricity to 38,000 Danish households and reduce carbon dioxide emissions by 106,000 tons annually.
Chinese companies’ overseas investments in clean energy cover major areas such as wind power, solar power, and hydropower, helping other countries achieve their carbon reduction goals. This has created new industries and employment opportunities, promoting common development and prosperity.
In 2023, China exported over 1.2 million new energy vehicles, representing a year-on-year growth of 77.6 percent. This has positioned China as a significant force leading the transformation in the global automotive industry.
Chinese-manufactured electric buses can be seen cruising the streets of Rwanda, contributing to local environmental initiatives. Additionally, Chinese automakers have established new energy vehicle factories in Thailand, assisting the upgrading of the country’s automotive industry.
These facts demonstrate that China’s new energy industry provides high-quality production capacity that contributes to the implementation of the UN 2030 Agenda for Sustainable Development and the goals of the Paris Agreement. All countries can benefit from it. From a global perspective, the more of this capacity, the better.
Climate change is a global challenge, and the development of the new energy industry and the achievement of green and low-carbon transformation are common aspirations of all countries.
China has achieved rapid development in the new energy industry through technological innovation, a well-established supply chain system, and market competition. With an open attitude, it actively engages in international cooperation, bringing opportunities for green and win-win development to countries around the world.
China looks forward to continuing to work with all parties to promote the high-quality development of the new energy industry, so as to enhance the well-being of all humanity, and contribute to the building of a clean and beautiful world.
The post Chinese new energy industry contributes to global green, low-carbon transition appeared first on HIPTHER Alerts.

Continue Reading

Trending